Log in
E-mail
Password
Remember
Forgot password ?
Become a member for free
Sign up
Sign up
New member
Sign up for FREE
New customer
Discover our services
Settings
Settings
Dynamic quotes 
OFFON

MarketScreener Homepage  >  Equities  >  Xetra  >  Merck KGaA    MRK   DE0006599905

MERCK KGAA

(MRK)
  Report
SummaryQuotesChartsNewsRatingsCalendarCompanyFinancialsConsensusRevisions 
SummaryMost relevantAll NewsPress ReleasesOfficial PublicationsSector newsMarketScreener StrategiesAnalyst Recommendations

MERCK KGAA : JP Morgan remains Neutral

10/27/2020 | 06:28am EST

Initially Neutral on the company, JP Morgan's analyst Richard Vosser maintained his recommendation. The target price continues to be set at EUR 130.


© MarketScreener with dpa-AFX Analyser 2020
All news about MERCK KGAA
04:21aMerck KGaA agrees research deal with Artios for 'DNA damage' cancer drugs
RE
04:02aMerck KGaA agrees research deal with Artios for 'DNA damage' cancer drugs
RE
03:49aMERCK : Enters Research Agreement With Artios on Precision Oncology Treatments
DJ
12/01MERCK : to Accelerate Commercialization of OLED Display Materials Through Partne..
DJ
11/30MERCK KGAA : Gets a Buy rating from Kepler Cheuvreux
MD
11/26MERCK : Partners With Siemens on New Plant
DJ
11/24Deutsche Bank's Depositary Receipts Virtual Investor Conference presentations..
AQ
11/24MERCK KGAA : Correction of a release from 25/03/2020 according to Article 40, Se..
EQ
11/23MERCK : Massachusetts-based Businesses of Merck KGaA, Darmstadt, Germany named t..
AQ
11/23MERCK KGAA : Release according to Article 40, Section 1 of the WpHG [the German ..
EQ
More news
Financials
Sales 2020 17 381 M 21 149 M 21 149 M
Net income 2020 2 013 M 2 449 M 2 449 M
Net Debt 2020 11 224 M 13 658 M 13 658 M
P/E ratio 2020 29,0x
Yield 2020 1,04%
Capitalization 58 782 M 71 018 M 71 526 M
EV / Sales 2020 4,03x
EV / Sales 2021 3,74x
Nbr of Employees 58 077
Free-Float 29,7%
Chart MERCK KGAA
Duration : Period :
Merck KGaA Technical Analysis Chart | MarketScreener
Full-screen chart
Technical analysis trends MERCK KGAA
Short TermMid-TermLong Term
TrendsNeutralBullishBullish
Income Statement Evolution
Consensus
Sell
Buy
Mean consensus OUTPERFORM
Number of Analysts 22
Average target price 135,37 €
Last Close Price 135,20 €
Spread / Highest target 25,0%
Spread / Average Target 0,12%
Spread / Lowest Target -25,3%
EPS Revisions
Managers
NameTitle
Stefan Oschmann Chairman-Executive Board & CEO
Wolfgang Heinz Büchele Chairman-Supervisory Board
Marcus Kuhnert Chief Financial Officer
Christian Raabe Independent Member-Supervisory Board
Edeltraud Glänzer Independent Member-Supervisory Board
Sector and Competitors
1st jan.Capitalization (M$)
MERCK KGAA28.33%71 018
ZHANGZHOU PIENTZEHUANG PHARMACEUTICAL., LTD102.43%20 446
KYOWA KIRIN CO., LTD.12.01%14 808
BETTA PHARMACEUTICALS CO., LTD.40.61%5 673
YUHAN CORPORATION37.84%3 515
RECIPHARM AB (PUBL)32.26%2 057